Comparison of Ultrasound-guided Steroid Injection and Dry Needling in Piriformis Muscle Syndrome

Piriformis Muscle Syndrome Clinical Trial

Official title:

Comparison of Efficacy of Ultrasound-Guided Steroid Injection and Dry Needling in Piriformis Muscle Syndrome

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06095180
• Other study ID #: 41
• Status: Not yet recruiting
• Phase: N/A
• Start date: November 28, 2023
• Est. completion date: August 26, 2024

Study information

• Verified date: October 2023
• Source: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
• Contact: Aysenur Simsek Yaglioglu, MD
• Phone: +903122912444
• Email: aysenursimsek33[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to to compare its effectiveness ultrasound-guided steroid injection, dry needling treatments and exercises in patients diagnosed with piriformis syndrome.

Description:

Piriformis syndrome is a painful entrapment neuropathy caused by compression of the sciatic nerve under the piriformis muscle. The most common cause is myofascial pain syndrome. There is no gold standard treatment for piriformis syndrome. The main purpose of treatment methods is to reduce local pain, muscle tension and spasm. This work; it will contribute to the literature by comparing steroid, dry needling and exercise treatments in patients with piriformis syndrome.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: August 26, 2024
• Est. primary completion date: August 26, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

1. Age between 18-60,

2. Hip pain for =1 month

3. Local piriformis pain with prolonged sitting (>20 minutes) and increased sensitivity

4. Patients with suspected piriformis syndrome based on clinical maneuvers

5. Signing and informed consent from showing consent to participate in the study

Exclusion Criteria:

1. Hip surgery

2. Lumbar disc disease

3. History of inflammatory hip disease

4. Medical treatment for pain is started

5. Neurological deficit

6. Breastfeeding or pregnant

7. Allergy to local anesthetic

8. Use of anticoagulants

9. Body mass index >35

10. Active psychiatric illness

11. Uncontrolled hypertension and diabetes mellitus disease

12. Noncompensated chronic lung/heart/renal failure

13. History of vascular/tumoral disease

Related Conditions & MeSH terms

• Piriformis Muscle Syndrome
• Syndrome

Intervention

Other:
• corticosteroid injection
In the steroid group, 4 mL lidocaine 2% + 1 mL betamethasone injection will be administered under ultrasound guidance and conventional treatment will be given (conventional treatment includes piriformis stretching exercises. It will be stated that patients should do 2 sets a day and each set should be 10 repetition)
• dry needling
In the dry needling group, a total of 3 sessions of dry needling will be performed once a week using a 0.60×100 mm sterile needle under ultrasound guidance and conventional treatment will be given ((conventional treatment includes piriformis stretching exercises. It will be stated that patients should do 2 sets a day and each set should be 10 repetition)
• exercise
The conventional treatment group (control group) will be given piriformis stretching exercises including hip and knee flexion, hip abduction and external rotation in the supine position. It will be stated that patients should do 2 sets a day and each set should be 10 repetitions.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analogue Scale (VAS) (Sitting)	Average hip pain intensity in a sitting position over the past 24 hours, a visual analog scale. (VAS; ranging from 0 to 10, 0 = no pain and 10 = worst possible pain)	at baseline and change from baseline VAS (sitting) at 4 weeks and 12 weeks
Primary	Visual Analog Scale (VAS) (Resting)	Average hip pain intensity at rest over the past week is a visual analog scale. (VAS; ranging from 0 to 10, 0 = no pain and 10 = worst possible pain)	at baseline and change from baseline VAS (resting) at 4 weeks and 12 weeks
Primary	Visual Analog Scale (VAS) (Movement)	Average hip pain intensity during movement over the past 1 week is a visual analog scale. (VAS; ranging from 0 to 10, 0 = no pain and 10 = worst possible pain)	at baseline and change from baseline VAS (movement) at 4 weeks and 12 weeks
Secondary	Oswestry disability index (ODI)	ODI includes questions regarding pain severity, sexual function, sleep quality and personal care, ability to work, sit, walk, lift, stand and travel. Total score ranges from 0-50, with higher scores indicating more injury.	at baseline and change from baseline ODI at 4 weeks and 12 weeks